InsidersTradesSigma
Bausch & Lomb Corp: directors' dealings · United States · SEC (Form 4)
SEC:bausch-and-lomb-corp-f13113US·SEC (Form 4)Mcap 5.7Bn€Healthcare
Explore the full insider trade history of Bausch & Lomb Corp, a listed equity based in United States. Shares are quoted on US US, under the authority of SEC (Form 4). Operating in the Healthcare sector, Bausch & Lomb Corp has published 17 public disclosures. Market capitalisation: €5.7bn. The latest transaction was disclosed on 30 June 2022 — Attribution. Among the most active insiders: Bausch Health Companies Inc.. Every trade is free.
17
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
€640m
2 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
16.09 €
Analyst consensus
13 analystsHold
16.00 €Target 18.04 €(+12%)21.00 €
Income statement
Revenue5.10 Bn€
Gross profit3.05 Bn€60% margin
Net income−360.0 M€-4.2% margin
Valuation
PER (forward)15.1x
P/Book0.9x
Beta0.59
Balance sheet & cash
Market cap5.74 Bn€
Total debt5.08 Bn€
Free Cash Flow−66.0 M€
Debt / Equity79%
Profitability & ownership
ROE-3.3%
ROA1.4%
% insiders87.6%
% institutions11.0%
Last declaration on 30 June 2022
Declarations0 total
No declarations found
0 of 0 declarations